La maladie de Parkinson en France (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Oxidopamine (toxicity) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Oxidopamine (pharmacology) < Oxidopamine (toxicity) < Oxidoreductases (metabolism)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 17.
Ident.Authors (with country if any)Title
000088 (1999) V. Ben [France] ; O. Blin ; B. BruguerolleTime-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions.
000450 (2004) Günter U. Höglinger [France] ; Pamela Rizk ; Marie P. Muriel ; Charles Duyckaerts ; Wolfgang H. Oertel ; Isabelle Caille ; Etienne C. HirschDopamine depletion impairs precursor cell proliferation in Parkinson disease.
000541 (2006) Mara Brizard [France] ; Carole Carcenac ; Alexis-Pierre Bemelmans ; Claude Feuerstein ; Jacques Mallet ; Marc SavastaFunctional reinnervation from remaining DA terminals induced by GDNF lentivirus in a rat model of early Parkinson's disease.
000901 (2009) Lydia Kerkerian-Le Goff [France] ; Jean-Jacques Bacci ; Loreline Jouve ; Christophe Melon ; Pascal SalinImpact of surgery targeting the caudal intralaminar thalamic nuclei on the pathophysiological functioning of basal ganglia in a rat model of Parkinson's disease.
000940 (2009) Christelle Monville [France] ; Eduardo M. Torres ; Vladimir Pekarik ; Emma L. Lane ; Stephen B. DunnettGenetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA model.
000B44 (2010) Audrey Boulamery [France] ; Nicolas Simon ; Johanna Vidal ; Bernard BruguerolleEffects of L-Dopa on circadian rhythms of 6-OHDA striatal lesioned rats: a radiotelemetric study.
000D60 (2012) Mickael Decressac [France] ; Stéphanie Pain ; Pierre-Yves Chabeauti ; Laura Frangeul ; Nathalie Thiriet ; Herbert Herzog ; Jackie Vergote ; Sylvie Chalon ; Mohamed Jaber ; Afsaneh GaillardNeuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease.
001068 (2013) Erwan Bezard [France] ; Elisabetta Tronci ; Elsa Y. Pioli ; Qin Li ; Gregory Porras ; Anders Björklund ; Manolo CartaStudy of the antidyskinetic effect of eltoprazine in animal models of levodopa-induced dyskinesia.
001150 (2013) Omar Ouachikh [France] ; Wisam Dieb ; Franck Durif ; Aziz HafidiDifferential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area.
001181 (2013) Angélique Virgone-Carlotta [France] ; Josselin Uhlrich ; Muhammad Numan Akram ; Denis Ressnikoff ; Fabrice Chrétien ; Chantal Domenget ; Romain Gherardi ; Geneviève Despars ; Pierre Jurdic ; Jérôme Honnorat ; Serge Nataf ; Monique TouretMapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease.
001212 (2013) Jonathan Chetrit [France] ; Anne Taupignon ; Lionel Froux ; Stephanie Morin ; Rabia Bouali-Benazzouz ; Frédéric Naudet ; Nabila Kadiri ; Christian E. Gross ; Bernard Bioulac ; Abdelhamid BenazzouzInhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.
001603 (2015) Anthony Bosson [France] ; Sylvie Boisseau ; Alain Buisson ; Marc Savasta ; Mireille AlbrieuxDisruption of dopaminergic transmission remodels tripartite synapse morphology and astrocytic calcium activity within substantia nigra pars reticulata.
001670 (2015) Gaynor A. Smith [États-Unis] ; Emily M. Rocha [États-Unis] ; Thomas Rooney [France] ; Pascal Barneoud [France] ; Jesse R. Mclean [États-Unis] ; Jonathan Beagan [États-Unis] ; Teresia Osborn [États-Unis] ; Madeleine Coimbra [France] ; Yongyi Luo [États-Unis] ; Penelope J. Hallett [États-Unis] ; Ole Isacson [États-Unis]A Nurr1 Agonist Causes Neuroprotection in a Parkinson’s Disease Lesion Model Primed with the Toll-Like Receptor 3 dsRNA Inflammatory Stimulant Poly(I:C)
001690 (2015) C. Fidalgo [Italie] ; W K D. Ko [Royaume-Uni] ; E. Tronci [Italie] ; Q. Li [République populaire de Chine] ; R. Stancampiano [Italie] ; Q. Chuan [République populaire de Chine] ; E. Bezard [République populaire de Chine] ; M. Carta [Italie]Effect of serotonin transporter blockade on L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
001732 (2015) H. Iderberg [Suède] ; A C Mccreary [Pays-Bas] ; M A Varney [États-Unis] ; M S Kleven [France] ; W. Koek [France] ; L. Bardin [France] ; R. Depoortère [France] ; M A Cenci [Suède] ; A. Newman-Tancredi [États-Unis]NLX-112, a novel 5-HT1A receptor agonist for the treatment of L-DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat.
001802 (2016) Aderbal Silva Aguiar [Brésil] ; Marcelo Duzzioni [Brésil] ; Aline Pertile Remor [Brésil] ; Fabrine Sales Massafera Tristão [France] ; Filipe C. Matheus [Brésil] ; Rita Raisman-Vozari [France] ; Alexandra Latini [Brésil] ; Rui Daniel Prediger [Brésil]Moderate-Intensity Physical Exercise Protects Against Experimental 6-Hydroxydopamine-Induced Hemiparkinsonism Through Nrf2-Antioxidant Response Element Pathway.
001E92 (1997) P. Horellou [France] ; J. MalletGene therapy for Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Oxidopamine (toxicity)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Oxidopamine (toxicity)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Oxidopamine (toxicity)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024